MYELOKATHEXIS

Clinical trials for MYELOKATHEXIS explained in plain language.

Never miss a new study

Get alerted when new MYELOKATHEXIS trials appear

Sign up with your email to follow new studies for MYELOKATHEXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial offers hope for rare immune disorder

Disease control Recruiting now

This study is testing whether Mozobil, a drug already used for bone marrow transplants, can safely improve white blood cell counts in adults with WHIMS syndrome. WHIMS is a rare genetic disorder that causes severe infections, warts, and low white blood cells. Researchers will giv…

Matched conditions: MYELOKATHEXIS

Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control

Last updated Apr 21, 2026 12:44 UTC

MYELOKATHEXIS

Get alerted when new MYELOKATHEXIS trials appear

New drug trial offers hope for rare immune disorder